Medical device maker Microlife Corp (百略) yesterday said revenue would rise by 4 to 5 percent this year from last year on expectations of higher sales of its new sphygmomanometers.
The company aims to increase shipments of its new sphygmomanometers, launched in the middle of last year, by 30 percent this year from 250,000 units last year, vice president Edith Huang (黃雅絹) said.
The new product is priced at NT$4,500 (US$149) per unit, compared with NT$2,000 per unit for previous models, Huang said, adding that its gross margin is estimated to be 10 percent higher than earlier versions.
The new machine can measure blood pressure three times and calculate the average, Huang said. It can also test whether a patient has atrial fibrillation, which may lead to myocardial infarction and stroke, he said.
Microlife made the remarks after a ceremony where the company donated 1,000 new sphygmomanometers to 30 local hospitals yesterday.
The company also produces medical thermometers and electric blankets.
The company has set up 24 service points at local drug stores and medical device shops, where people can use its new sphygmomanometers for free. It plans to raise the number of service points to 100 around the nation by the end of this year, Huang said.
“Many Taiwanese still do not recognize the danger of atrial fibrillation, and we believe our new product can help prevent stroke and myocardial infarction,” Huang said.
Microlife sold about 5 million sphygmomanometers a year, accounting for 60 percent of its total revenue, he said.
Last year, the company reported revenue of NT$6.28 billion, up 9.6 percent from NT$5.73 billion a year ago, according to the company’s filing to the Taiwan Stock Exchange.
The US and Europe each accounted for 40 percent of its revenue last year, while Asia contributed 20 percent, Huang said.
Last quarter, Microlife saw revenue increase 4.53 percent to NT$967.15 million from NT$925.22 million the previous year.
Huang said the company’s revenue is expected to rise sequentially this quarter and next quarter, but would decline slightly in the fourth quarter.
The company posted a stronger performance in the second half of last year because it started to sell electric blankets in the third quarter, Huang said.
Microlife shares rose 1 percent to NT$80.70 yesterday, outperforming the over-the-counter index, which advanced 0.37 percent.
Elon Musk’s lieutenants have reached out to chip industry suppliers, including Applied Materials Inc, Tokyo Electron Ltd and Lam Research Corp, for his envisioned Terafab, early steps in an audacious and likely arduous attempt to break into the production of cutting-edge chips. Staff working for the joint venture between Tesla Inc and Space Exploration Technologies Corp (SpaceX) have sought price quotes and delivery times for an array of chipmaking gear, people familiar with the matter said. In past weeks, they’ve contacted makers of photomasks, substrates, etchers, depositors, cleaning devices, testers and other tools, according to the people, who asked not to
The EU and US are nearing an agreement to coordinate on producing and securing critical minerals, part of a push to break reliance on Chinese supplies. The potential deal would create incentives, such as minimum prices, that could advantage non-Chinese suppliers, according to a draft of an “action plan” seen by Bloomberg. The EU and US would also cooperate on standards, investments and joint projects, as well as coordinate on any supply disruptions by countries like China. The two sides are additionally seeking other “like-minded partners” to join a multicountry accord to help create these new critical mineral supply chains, which feed into
Japan approved ￥631.5 billion (US$3.97 billion) in additional subsidies to hasten Rapidus Corp’s entry into the high-stakes artificial intelligence (AI) chipmaking arena, ramping up support for a project widely regarded as a long shot. The capital is intended to bankroll Rapidus’ work for information technology firm Fujitsu Ltd, one of the initial customers that Tokyo hopes would get the signature endeavor off the ground. The new money raises the fees and investments that the government is injecting into the start-up to ￥2.6 trillion by the end of the current fiscal year to March next year, the Japanese Ministry of Economy, Trade and
The founder of Chinese property giant Evergrande Group (恆大集團) has pleaded guilty to charges of fraud and bribery, a court said yesterday, the latest blow for what was once the country’s leading developer. Evergrande’s rise was propelled by decades of rapid urbanization and rising living standards, but in 2020, its access to credit dramatically narrowed when the government introduced curbs on excessive borrowing and speculation. The company defaulted in 2021 after struggling to repay creditors. Founder Xu Jiayin (許家印), 67, known as Hui Ka Yan in Cantonese, was reportedly held by police in 2023, with Evergrande saying he had been subjected to
RSS